by Skin grafting devices are primarily used to treat severe burns and wounds by transplanting healthy skin tissue to the affected area. These devices help to minimize the risks associated with skin grafting procedures. Various types of skin grafting devices available in the market include dermatomes, general knives, skin graft meshers and skin scrapers. Dermatomes help in obtaining uniform thick grafts from the donor site with minimum discomfort, while meshers help in preparing skin grafts into a meshed pattern to achieve maximum coverage of wounds. These advanced devices play a key role in decreasing donor skin damage and reducing operation time as compared to the conventional methods. The global skin grafting device market witnesses high demand for complex wound management with the increasing prevalence of burn injuries across the globe. The growing awareness regarding advanced treatment options and rising healthcare expenditure are further contributing to market growth.
The global Skin Grafting Device Market is estimated to be valued at US$ 942.3 million in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as highlighted in a new report published by CoherentMI.
Market Key Trends:
One of the key trends witnessed in the global skin grafting device market includes growing adoption of advanced skin grafting technologies. Companies are focusing on development of innovative devices to simplify graft harvesting and accelerate wound healing. For instance, 3M Health Care has developed Regenerative Tissue Matrix (RTM) skin substitute, which is an acellular dermal matrix made from donated human dermal tissue. RTM helps in enhancing graft acceptance and takes over wound contracture. Similarly, availability of mesher devices integrated with motorized function has improved the procedure efficacy and handling convenience for healthcare professionals. Such advanced technologies are expected to augment the market growth over the forecast period.
Porter’s Analysis:
Threat of new entrants: Low as the skin grafting device market requires significant investments in R&D to develop new technologies and gain regulatory approvals. There are also economies of scale for existing players.
Bargaining power of buyers: Moderate as the major buyers in this market are hospitals and burn centers. They can compare products and prices to negotiate better deals.
Bargaining power of suppliers: Moderate as raw material prices are stable and a few large suppliers exist for specialized components required. Switching costs are also moderate.
Threat of new substitutes: Low as there are currently no major substitutes for skin grafts in treating large burn wounds and skin disorders.
Competitive rivalry: High as the key players invest heavily in new product development and acquisition activities to gain market share.
Skin Grafting Device Market Segmentation:
By Product Type
Dermal Substitutes
Acellular
Cellular Allogeneic
Cellular Autologou
By Graft Thickness
Split-Thickness
Full-Thickness
Composite Grafts
By Application
Burns
Traumatic Wounds
Surgical Wounds
Chronic Wounds
Others
By End user
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Key Takeaways:
The global Skin Grafting Device Market Size is expected to witness high growth over the forecast period. The global Skin Grafting Device Market is estimated to be valued at US$ 942.3 million in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030.
From a regional perspective, North America is expected to continue dominating the market owing to rising incidence of burns and skin disorders. The availability of advanced treatment facilities and favorable reimbursement policies also support market growth. Europe is also a major regional market for skin grafting devices due to increasing awareness about skin treatment options. Asia Pacific is poised to be the fastest growing market with rapid economic development leading to investments in healthcare infrastructure and rising medical tourism across countries such as India and China.
Key players operating in the skin grafting device market are Avita Medical, Smith & Nephew, MiMedx Group, Organogenesis, Zimmer Biomet, Medtronic, Tissue Regenix, Integra Lifesciences, Anika Therapeutics, and Nouvag. These companies have strong foothold through their extensive distribution networks and continuous product launches to meet the growing demand. They also engage in acquisitions to enhance their skin graft portfolio.
*Note:
1. Source: CoherentMI, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
